ArticleStatistics in medicine2025

UNITED: A Unified Transparent and Efficient Phase I/II Trial Design for Dose Optimization Accounting for Ordinal Graded, Continuous and Mixed Toxicity and Efficacy Endpoints.

Mingyue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.